Shots: Abbott’s SARS-CoV-2 IgG lab-based serology blood test is the fourth COVID-19 detection test to receive the FDA’ EUA based on Alinity i platforms, which is a next-generation immunoassay instrument offering efficiency to lab clinicians for running tests SARS-CoV-2 IgG lab-based serology blood test is a reliable test for customers and patients to detect Abs […]Read More
1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019 Date – Oct 01, 2019 Product – Zirabev (biosimilar, bevacizumab) The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept […]Read More
Shots: The Fourth ODD is based on the ongoing P-III POLO study assessing Lynparza (300mg bid) as monotherapy vs PBO in ratio (3:2) & 1EP as PFS in 145 patients with BRCA-mutated mPC Results of POLO P-III study is expected in H1’19 In Oct 2013, Lynparza received ODD for the treatment of ovarian cancer and […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
